Bridgeway Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-50,200
| Closed | -$83K | – | 1316 |
|
|
2020
Q1 | $83K | Sell |
50,200
-27,100
| -35% | -$44.8K | ﹤0.01% | 1191 |
|
|
2019
Q4 | $172K | Sell |
77,300
-70,000
| -48% | -$156K | ﹤0.01% | 1214 |
|
|
2019
Q3 | $314K | Sell |
147,300
-57,600
| -28% | -$123K | ﹤0.01% | 1088 |
|
|
2019
Q2 | $549K | Buy |
204,900
+81,200
| +66% | +$218K | 0.01% | 949 |
|
|
2019
Q1 | $609K | Buy |
+123,700
| New | +$609K | 0.01% | 964 |
|